OQROSign up free
Politician trade (House)

Moderna (MRNA): Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a purchase $1K–$15K

Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a purchase of Moderna in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
21 days
Disclosure lag
Traded
Oct 20, 2026
Disclosed
Nov 10, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 19, 2026Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  2. Aug 27, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 2 more items)
  3. Sep 1, 2026InsiderOfficer sold ~$486K of MRNA shares in the open market
  4. Sep 10, 2026Insider · 1 personInsiders: 2 sales (~$4.7M)
  5. Sep 14, 2026InsiderOfficer sold ~$5.81M of MRNA shares in the open market
  6. Sep 15, 2026InsiderOfficer sold ~$5.88M of MRNA shares in the open market
  7. Sep 24, 2026CongressDisclosed partial sale of MRNA — reported range $1,001 - $15,000
  8. Sep 30, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 30, 2026, Moderna, Inc. (“Moderna” or the “Company”) announced the appointment of Juan Andres as its Chief Operating Officer (“COO”) effective October 5, 2026.”
  9. Oct 14, 2026Insider · 1 personInsiders: 2 sales (~$8.4M)
  10. Oct 15, 2026InsiderOfficer sold ~$8.64M of MRNA shares in the open market
  11. Oct 20, 2026 · this disclosureCongressDisclosed purchase of MRNA — reported range $1,001 - $15,000

What came next

  1. Nov 5, 20265% stakeFMR LLC reported a passive stake (13G) of 14.8%
  2. Nov 6, 2026Company filing · Form 8-K · ResultsReported its results
  3. Nov 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 13, 2026 , Moderna, Inc. (the “Company”) entered into a Transitional Services and Retirement Agreement (the “Retirement Agreement”) with Shannon Thyme Klinger, the Company’s Chief Legal Officer, that sets forth the terms of Ms. Klinger’s retirement from the Company.”
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Moderna

For Moderna, OQRO holds 13 insider filings (SEC Form 4 or Form 144) and 4 Congress trade reports dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MRNA page.

Other recent filings by Rep. Gilbert Ray Cisneros Jr. (CA31)

The full history of Rep. Gilbert Ray Cisneros Jr. (CA31) is on the profile page.

How this filing works

Explore the data

Other disclosures at Moderna

Everything OQRO holds on this company is on its MRNA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data